In focus · trending topic

SUCAMPO PHARMACEUTICALS

20 stories · following the connections

Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results

By Nasdaq OMXMar 8, 2017, 11:30 AM UTC

Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call

By Nasdaq OMXFeb 23, 2017, 9:02 PM UTC

Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021

By Nasdaq OMXDec 21, 2016, 7:00 AM UTC

Sucampo Provides Update to 2015 and Confirms 2016 Financial Guidance Post Closing of R-Tech Ueno Acquisition

By Nasdaq OMXJan 7, 2016, 12:00 PM UTC